C4 Therapeutics Inc (CCCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,780 | -128,175 | -90,990 | -59,032 | -31,620 |
| Depreciation Amortization | 75 | 3,103 | 2,807 | 2,176 | 1,145 |
| Accounts receivable | 945 | 4,244 | 4,229 | 4,007 | 3,944 |
| Accounts payable and accrued liabilities | -138 | -3,333 | -2,257 | -564 | -1,152 |
| Other Working Capital | -6,220 | -16,779 | -16,119 | -11,911 | -6,243 |
| Other Operating Activity | 6,993 | 35,001 | 25,519 | 16,533 | 7,330 |
| Operating Cash Flow | $-33,125 | $-105,939 | $-76,811 | $-48,791 | $-26,596 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -11,437 | -219,527 | -163,238 | -108,132 | -76,219 |
| PPE Investments | -589 | -5,496 | -4,006 | -701 | -172 |
| Sale Of Investment | 65,557 | 283,445 | 216,382 | 138,057 | 72,387 |
| Investing Cash Flow | $53,531 | $58,422 | $49,138 | $29,224 | $-4,004 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -750 | N/A | 0 | N/A | N/A |
| Common Stock Issued | 56 | 777 | 730 | 519 | 260 |
| Common Stock Repurchased | -94 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 104 | 370 | 370 | 220 | 220 |
| Financing Cash Flow | $-684 | $1,147 | $1,100 | $739 | $480 |
| Beginning Cash Position | 33,033 | 79,403 | 79,403 | 79,403 | 79,403 |
| End Cash Position | 52,755 | 33,033 | 52,830 | 60,575 | 49,283 |
| Net Cash Flow | $19,722 | $-46,370 | $-26,573 | $-18,828 | $-30,120 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,125 | -105,939 | -76,811 | -48,791 | -26,596 |
| Capital Expenditure | -589 | -5,496 | -4,006 | -701 | -172 |
| Free Cash Flow | -33,714 | -111,435 | -80,817 | -49,492 | -26,768 |